Table 5. Statistics of differential splicing genes in bladder cancer.

Pattern of alternative splicing	# of differential splicing events (percentage)	# of unique differential splicing genes (percentage)
A3SS: Alternative 3′splice sites	49(10.61%)	47(12.05%)
A5SS: Alternative 5′splice sites	52(11.26%)	46(11.79%)
AFE: Alternative first exons	14(3.03%)	10(2.56%)
MXE: Mutually exclusive exons	14(3.03%)	13(3.33%)
RI: Retained introns	101(21.86%)	95(24.36%)
SE: Skipped exons	232(50.22%)	203(52.05%)
TUTR: Tandem 3′UTRs	0(0.00%)	0(0.00%)
TOTAL	462(100.00%)	390(100.00%)